amphetamine has been researched along with kn 93 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gnegy, ME; Hewlett, GH; Kantor, L | 1 |
| Tan, SE | 1 |
| Dipace, C; Galli, A; Javitch, JA; Saunders, C; Sung, U; Wei, Y; Williams, JM | 1 |
| Sakurai, S; Tan, SE; Yu, L | 1 |
| Baker, LK; Guillory, AM; Guptaa, T; Loweth, JA; Vezina, P | 1 |
| Blakely, RD; Bowton, E; Galli, A; Gill, M; Hamilton, PJ; Han, Q; Mazei-Robison, MS; Mergy, MA; Richtand, NW; Sakrikar, D; Veenstra-Vanderweele, J | 1 |
| Andresen, B; Daws, LC; Gether, U; Jørgensen, TN; Madsen, KL; Owens, WA; Rathje, M; Rickhag, M; Sitte, H; Strandfelt, KN; Sørensen, G; Winkler, MT; Woldbye, DPD; Wörtwein, G | 1 |
7 other study(ies) available for amphetamine and kn 93
| Article | Year |
|---|---|
Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles.
Topics: Amphetamine; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Corpus Striatum; Dopamine; Enzyme Inhibitors; Female; Membrane Potentials; Phosphorylation; Potassium; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reserpine; Sulfonamides; Synaptic Vesicles | 1999 |
Impairing the amphetamine conditioning in rats through the inhibition of hippocampal calcium/calmodulin-dependent protein kinase II activity.
Topics: Amphetamine; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Central Nervous System Stimulants; Conditioning, Psychological; Enzyme Inhibitors; Hippocampus; Male; Rats; Rats, Wistar; Sulfonamides | 2002 |
Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
Topics: Amphetamine; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sulfonamides; Synaptosomes | 2007 |
Roles of hippocampal N-methyl-D-aspartate receptors and calcium/calmodulin-dependent protein kinase II in amphetamine-produced conditioned place preference in rats.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Behavior, Animal; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Central Nervous System Stimulants; Conditioning, Operant; Cycloserine; Excitatory Amino Acid Agonists; Hippocampus; Immunoblotting; Male; Motor Activity; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Sulfonamides | 2007 |
Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats.
Topics: Amphetamine; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Stimulants; Conditioning, Operant; Male; Microinjections; Nucleus Accumbens; Rats; Rats, Long-Evans; Reinforcement Schedule; Self Administration; Sulfonamides | 2008 |
Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
Topics: Adolescent; Amphetamine; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Benzylamines; Biotinylation; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Transformed; Child; Child, Preschool; Cholera Toxin; Cohort Studies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Female; Humans; Immunoprecipitation; Luminescent Proteins; Male; Membrane Microdomains; Membrane Proteins; Piperazines; Polymorphism, Single Nucleotide; Protein Kinase Inhibitors; Protein Transport; Sulfonamides; Transfection; Tritium | 2012 |
Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
Topics: Amphetamine; Animals; Benzylamines; Cell-Penetrating Peptides; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Male; Mice; Motor Activity; PDZ Domains; Protein Kinase C-alpha; Protein Kinase Inhibitors; Sulfonamides | 2013 |